AzTrials
AzTrials

Postoperative Agitation of PatientsPhase 4NCT02017392

A RCT of Compound Lidocaine Cream to Prevent Postoperative Agitation in Patients With Endotracheal Intubation for GA

A Phase 4 study testing Compound Lidocaine Cream in people with Postoperative Agitation of Patients, run by Third Affiliated Hospital, Sun Yat-Sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether the compound lidocaine cream is effective in preventing postoperative agitation in patients with endotracheal intubation for general anesthesia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Agitation of Patients
What is being tested?
Compound Lidocaine Cream
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,000 participants
Where
1 siteChina
Study dates
Dec 2013to Apr 2014
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged over 18
  • selective operation patients with endotracheal intubation for general anesthesia

Who cannot join

  • highly sensitive to local anesthetics of amide derivatives or anything else in compound lidocaine cream
  • congenital or idiopathic methemoglobinemia

Trial locations and contacts

1 site in 1 country.

Xun Liu, Associate Professor contact

13711692006

naturestyle@163.com

China1 site
  • The third affiliated hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510630

Other trials in China

About this study

Official title: A Randomized Controlled Study of Compound Lidocaine Cream to Prevent Postoperative Agitation in Patients With Endotracheal Intubation for General Anesthesia

The purpose of this study is to determine whether the compound lidocaine cream is effective in preventing postoperative agitation in patients with endotracheal intubation for general anesthesia.

Read the detailed description

This is a randomized controlled study. Some parameters were provided by preliminary test, provided theα=0.05,and β=0.20, the sample size can be estimated to be 2000 by the Open Epi Version 2.Patients will be recruited on the basis of predefined criterias. A researcher will take charge of the recruitment. Participants provide written consent and no financial incentives are provided. They are divided into experimental group and control group randomly. We need to collect their basic information including ages, genders, heights, weights, underlying diseases, surgical procedures and levels classified by ASA. Blood pressure, heart rate and other vital signs during the tube drawing process will be recorded. All the contents needed to be recorded had been compiled into a watch list with detailed instructions for filling in. All the personal information and observation records of participants will be kept in secret and only used for research. Developing standard operating procedure and training all the researchers. A third party will assess the accuracy, completeness and representativeness of registry data. Experimental data will be analysed with the help of statisticians.

Being tested
Compound Lidocaine Cream
Keywords
postoperative agitation, endotracheal intubation, general anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Compound Lidocaine CreamDrug

    Compound Lidocaine Cream ,1-2 grams per person.

Study groups in NCT02017392
Study groupRoleWhat they receive
Compound Lidocaine CreamExperimentalThe cuff of endotracheal tube is covered by 1-2g compound lidocaine cream before the general anesthesia.
Receives: Drug: Compound Lidocaine Cream
blank controlNo interventionNo intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vital signs like blood pressure and heart rates during extubation.

    Measured: an hour

Secondary outcomes (1)
  1. The cough reflex and breath holding during extubation.

    Measured: an hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2013 (estimated)
  2. Study startDec 2013
  3. Primary completionMar 2014 (estimated)
  4. Study completionApr 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02017392
Sponsor's protocol ID
[2013]2-85
Status last verified
Dec 2013
First submitted
16 Dec 2013
Last updated
20 Dec 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Batai I, Bogar L, Juhasz V, Batai R, Kerenyi M. A comparison of the antimicrobial property of lidocaine/prilocaine cream (EMLA) and an alcohol-based disinfectant on intact human skin flora. Anesth Analg. 2009 Feb;108(2):666-8. doi: 10.1213/ane.0b013e31818f887e.

    PubMed 19151306
  • Sawyer J, Febbraro S, Masud S, Ashburn MA, Campbell JC. Heated lidocaine/tetracaine patch (Synera, Rapydan) compared with lidocaine/prilocaine cream (EMLA) for topical anaesthesia before vascular access. Br J Anaesth. 2009 Feb;102(2):210-5. doi: 10.1093/bja/aen364.

    PubMed 19151049
  • Lv L, Yan L, Liu X, Chen M. Effectiveness of lidocaine/prilocaine cream on cardiovascular reactions from endotracheal intubation and cough events during recovery period of older patients under general anesthesia: prospective, randomized placebo-controlled study. BMC Geriatr. 2020 May 4;20(1):157. doi: 10.1186/s12877-020-01567-y.

    PubMed 32366224

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Compound Lidocaine Cream in people with Postoperative Agitation of Patients, run by Third Affiliated Hospital, Sun Yat-Sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Dec 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xun Liu, Associate Professor (13711692006, naturestyle@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vital signs like blood pressure and heart rates during extubation. (time frame: an hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02017392, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in